Greenovation to start Phase I clinical trial for moss-aGal
16 September 2015 | By Victoria White
Moss-aGal, a recombinant form of human alpha galactosidase, is the world´s first moss-produced drug candidate...
List view / Grid view
16 September 2015 | By Victoria White
Moss-aGal, a recombinant form of human alpha galactosidase, is the world´s first moss-produced drug candidate...